Back to search
Physiological Effects of Drugs
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Physiological Effects of Drugs trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Physiological Effects of Drugs trials you may qualify forThis is a multicenter, multinational, randomized, active-controlled, operationally seamless Phase 2/3 study of BMN 333 in treatment-naïve pediatric participants…
Phase 1/2, open-label study of ETX-636 in participants with advanced solid tumors
Mood disorders, such as depression and bipolar disorder, are difficult to treat. One reason is that there are no objective ways to measure how these disorders a…
This is a double-blind active placebo controlled clinical trial for individuals with moderate to severe depression. The purpose of this study is to assess if ne…
Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor…
ABBV-RGX-314 (also known as RGX-314 and surabgene lomparvovec (sura-vec)) is being developed as a novel one-time gene therapy for the treatment of neovascular (…
This is a Phase 2 non-randomized, open label, uncontrolled, efficacy and safety study. Study participants will receive two priming doses of 0.5mL of DPX-Surviva…
This is an active-comparator controlled study to evaluate the effect of sugammadex compared to neostigmine/glycopyrrolate for reversal of rocuronium on the inci…
The goal of this randomized clinical trial is to compare two different injection methods in children. The main question it aims to answer is: Is the needle-fre…